Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience

被引:15
|
作者
Tsitsikas, Dimitris A. [1 ]
Oakervee, Heather [1 ]
Cavenagh, Jamie D. [1 ]
Gribben, John [1 ]
Agrawal, Samir G. [1 ]
Mattes, Frank M. [2 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, Barts & London NHS Trust, Dept Haematol Oncol, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Barts & London NHS Trust, Dept Virol, London, England
关键词
palivizumab; ribavirin; respiratory syncytial virus; haemopoietic stem cell transplantation;
D O I
10.1111/j.1365-2141.2009.07763.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:574 / 576
页数:3
相关论文
共 50 条
  • [1] Treatment of respiratory syncytial virus infection with nebulised ribavirin and the humanised monoclonal antibody palivizumab in eight haemopoietic stem cell transplant recipients
    Tsitsikas, D. A.
    Oakervee, H.
    Cavenagh, J.
    Agrawal, S.
    Gribben, J.
    Mattes, F.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S252 - S253
  • [2] Empiric treatment of respiratory syncytial virus infection in adult stem cell transplant recipients with ribavirin and palivizumab.
    Stacy, T
    Connaghan, DG
    Holland, HK
    [J]. BLOOD, 2000, 96 (11) : 343B - 343B
  • [3] Efficacy of Oral Ribavirin in Respiratory Syncytial Virus Infection in Hematopoietic Stem Cell Transplant Patients: A Single-Centre Experience
    Philip, Shona
    Fulford, Adrienne
    Biederman, Krista
    Dorland, Brandon
    Xenocostas, Anargyros
    Deotare, Uday
    [J]. BLOOD, 2020, 136
  • [4] Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
    Foolad, Farnaz
    Aitken, Samuel L.
    Shigle, Terri Lynn
    Prayag, Amrita
    Ghantoji, Shashank
    Ariza-Heredia, Ella
    Chemaly, Roy F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (10) : 1641 - 1649
  • [5] Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion
    Meissner, HC
    Welliver, RC
    Chartrand, SA
    Law, BJ
    Weisman, LE
    Dorkin, HL
    Rodriguez, WJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (03) : 223 - 231
  • [6] Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
    Shah, Dimpy P.
    Ghantoji, Shashank S.
    Shah, Jharna N.
    El Taoum, Katia K.
    Jiang, Ying
    Popat, Uday
    Hosing, Chitra
    Rondon, Gabriela
    Tarrand, Jeffrey J.
    Champlin, Richard E.
    Chemaly, Roy F.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) : 1872 - 1880
  • [7] Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    Null, D
    Bimle, C
    Weisman, L
    Johnson, K
    Steichen, J
    Singh, S
    Wang, E
    Asztalos, E
    Loeffler, AM
    Azimi, PH
    Lieberman, JM
    O'Donnell, NE
    Cooke, RJ
    McCormick, K
    Koo, W
    Hammami, M
    Milner, AD
    Gaon, P
    Nachman, S
    Tarpey, KP
    Sánchez, PJ
    Broyles, RS
    Bratcher, D
    Ball, MV
    Duda, FJ
    DeCuir, PM
    Pollara, B
    Nelson, LS
    Balbus, M
    Schultz, MJ
    Chipps, BE
    Givner, LB
    O'Shea, M
    Everard, M
    Pfeffer, K
    Page, AJ
    Dennehy, PH
    Modlin, J
    Rhodes, T
    DeVincenzo, N
    Nickerson, B
    Arrieta, A
    Boucher, FD
    Keeney, RE
    Young, TE
    Stevens, JC
    Ariagno, R
    Adams, M
    Polak, MJ
    Lynch, SK
    [J]. PEDIATRICS, 1998, 102 (03) : 531 - 537
  • [8] Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
    Storch, GA
    [J]. PEDIATRICS, 1998, 102 (03) : 648 - 651
  • [9] Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients
    Boeckh, Michael
    Englund, Janet
    Li, Yufeng
    Miller, Carole
    Cross, Alan
    Fernandez, Humberto
    Kuypers, Jane
    Kim, Hyung
    Gnann, John
    Whitley, Richard
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 245 - 249
  • [10] Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients
    Permpalung, Nitipong
    Thaniyavarn, Tany
    Saullo, Jennifer L.
    Arif, Sana
    Miller, Rachel A.
    Reynolds, John M.
    Alexander, Barbara D.
    [J]. TRANSPLANTATION, 2020, 104 (06) : 1280 - 1286